Back
EHRA Premium Access

Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.

Session: Poster session 2 - Implantable Cardioverter / Defibrillator
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Mr J. Ramos Maqueda (Zaragoza, ES)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Mr Javier Ramos Maqueda

UNIVERSITY HOSPITAL CLINIC LOZANO BLESA, Zaragoza (Spain)
0 follower

14 more presentations in this session

Implantable cardioverter defibrillator and resynchronisation therapy in patients with dilated cardiomyopathy:efficiency in prevention of sudden cardiac death

Access
Like
Thumbnail

Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter defibrillator.

Speaker: Associate Professor I. Diemberger (Bologna, IT)

Access
Abstract
Like
Thumbnail

Appropriate and inappropriate ICD therapy with evidence-based programming: a real-world comparison with trial data

Speaker: Doctor M. Chapman (Middlesbrough, GB)

Access
Abstract
Like
Thumbnail

Determinants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization capabilities

Speaker: Doctor R. Brenner (St. Gallen, CH)

Access
Abstract
Slides
Like
Thumbnail

Day case complex devices - The state of the UK

Speaker: Doctor M. Waight (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 2 - Implantable Cardioverter / Defibrillator

Speakers: Mr J. Ramos Maqueda, Associate Professor I. Diemberger, Doctor M. Chapman, Doctor R. Brenner, Doctor M. Waight
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources